Sun Dong, Sun Qiufen, Ding Yinqi, Yu Canqing, Sun Dianjianyi, Pang Yuanjie, Pei Pei, Yang Ling, Millwood Iona Y, Walters Robin G, Du Huaidong, Zhang Jun, Schmidt Dan, Chen Junshi, Chen Zhengming, Li Liming, Lv Jun
Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
Genome Med. 2025 Jul 22;17(1):81. doi: 10.1186/s13073-025-01487-9.
Understanding the role of genetic risk and lifestyles on life expectancy (LE) without cardiovascular disease (CVD) and total LE may help optimize healthy aging strategies after taking genetic background into account.
The China Kadoorie Biobank recruited participants from five urban and five rural areas across China during 2004-2008 and followed them up till December 31, 2018. A polygenic risk score (PRS) comprising 3.5 million genetic variants for overall CVD was constructed by combining multiple PRSs for CVD and CVD-related risk factors in 96,400 participants. Genetic risk was categorized into low, intermediate, and high according to the PRS, and lifestyles were categorized as favorable, intermediate, and unfavorable according to the number of unfavorable lifestyles. Using multistate life tables, we estimated CVD-free and total LE at age 40 for different genetic and lifestyle risk groups.
Genetic risk was more strongly associated with CVD onset than post-CVD mortality. As a result, the increase in LE without CVD associated with low genetic risk (4.9 years (95% CI 4.3-5.5) for women and 4.4 years (3.6-5.1) for men) was greater than the increase in total LE (2.9 years (1.8-3.8) for women and 2.6 years (1.5-3.5) for men) when compared to high genetic risk. In contrast, the association strengths of lifestyles with CVD onset and mortality after CVD were similar. Correspondingly, compared to those with unfavorable lifestyles, participants with favorable lifestyles had longer total LE and LE without CVD of 3.0 (1.5-4.3) and 4.0 (3.0-4.9) years in women and 5.7 (4.1-7.1) and 5.8 (4.7-6.9) years in men, respectively. Participants with high genetic risk benefited more from favorable lifestyles than those with low and intermediate genetic risk, gaining 5.9 (2.3-9.3) and 5.3 (3.0-7.6) years in women and 6.1 (0.8-10.6) and 6.2 (2.3-9.8) years in men for total and CVD-free LE, respectively.
Improving lifestyles is critical for reducing CVD-related healthcare burden and promoting healthy aging, especially for individuals with high genetic risk.
了解遗传风险和生活方式对无心血管疾病(CVD)的预期寿命(LE)和总预期寿命的作用,可能有助于在考虑遗传背景的情况下优化健康老龄化策略。
中国嘉道理生物银行在2004年至2008年期间从中国五个城市和五个农村地区招募参与者,并对他们进行随访直至2018年12月31日。通过合并96400名参与者中CVD及CVD相关危险因素的多个多基因风险评分(PRS),构建了一个包含350万个基因变异的总体CVD多基因风险评分。根据PRS将遗传风险分为低、中、高,根据不良生活方式的数量将生活方式分为有利、中等和不利。使用多状态生命表,我们估计了不同遗传和生活方式风险组在40岁时无CVD和总预期寿命。
遗传风险与CVD发病的关联比CVD后死亡率更强。因此,与高遗传风险相比,低遗传风险与无CVD的预期寿命增加(女性为4.9年(95%CI 4.3 - 5.5),男性为4.4年(3.6 - 5.1))大于总预期寿命的增加(女性为2.9年(1.8 - 3.8),男性为2.6年(1.5 - 3.5))。相比之下,生活方式与CVD发病和CVD后死亡率的关联强度相似。相应地,与生活方式不利的参与者相比,生活方式有利的女性参与者的总预期寿命和无CVD预期寿命分别延长3.0(1.5 - 4.3)年和4.0(3.0 - 4.9)年,男性分别延长5.7(4.1 - 7.1)年和5.8(4.7 - 6.9)年。高遗传风险的参与者比低遗传风险和中等遗传风险的参与者从有利生活方式中获益更多,女性的总预期寿命和无CVD预期寿命分别增加5.9(2.3 - 9.3)年和5.3(3.0 - 7.6)年,男性分别增加6.1(0.8 - 10.6)年和6.2(2.3 - 9.8)年。
改善生活方式对于减轻与CVD相关的医疗负担和促进健康老龄化至关重要,特别是对于高遗传风险个体。